Search results (70)
« Back to PublicationsAssociation between surgeon experience, level of supervision, and outcomes after hip fracture
Journal article
Goh EL. et al, (2026), Bone & Joint Open
Economic Evaluation of Oral Nirmatrelvir-Ritonavir for COVID-19 in Higher Risk Outpatients: Evidence from the UK PANORAMIC Trial
Journal article
PNG ME. et al, (2026), JAMA Network Open
The utilisation and cost of social care after hip fracture: a prospective observational cohort study
Journal article
Goh EL. et al, (2026), Age and Ageing, 55
Clinical outcomes following treatment of extracapsular hip fractures with long compared with short cephalomedullary nails
Journal article
Goh EL. et al, (2025), Bone Joint Journal, 107-B, 1325 - 1332
The impact of complications on quality of life and mortality after hip fracture
Journal article
Goh EL. et al, (2025), Bone and Joint Journal, 107-B, 1118 - 1124
Risk factors associated with the development of complications after a hip fracture
Journal article
Goh EL. et al, (2025), Bone and Joint Journal, 107B, 950 - 956
A Viroimmunologic Model to Characterize the Antiviral Effect of Molnupiravir in Outpatients Infected With SARS-CoV-2: Implication for Treatment Duration
Journal article
Nguyen BT. et al, (2025), Journal of Infectious Diseases, 231, e1080 - e1090
Cost-effectiveness of routine COVID-19 adult vaccination programmes in England
Journal article
Keeling MJ. et al, (2025), Vaccine, 53
Cost-Effectiveness of Home-Based COVID-19 Treatments: Findings From the PRINCIPLE Trial
Conference paper
PNG M. et al, (2025)
Cost-Effectiveness of Home-Based COVID-19 Treatments: Findings From the PRINCIPLE Trial
Conference paper
PNG M. et al, (2025)
The risk of complications after hip fracture
Journal article
Goh EL. et al, (2025), Bone and Joint Journal, 107, 362 - 367
Prevalence of complications in older adults after hip fracture surgery
Journal article
Goh EL. et al, (2025), Bone and Joint Journal, 107 B, 139 - 148
Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trial
Journal article
Harris V. et al, (2025), The Lancet Infectious Diseases, 25, 68 - 79
Cost-effectiveness of osteoporotic fracture risk assessment in people with intellectual disabilities
Preprint
Png ME. et al, (2025)
Cost-utility analysis of molnupiravir for high-risk, community-based adults with COVID-19: the PANORAMIC trial
Journal article
Png ME. et al, (2024), British Journal of General Practice, 74, e570 - e579